Previous close | 0.0600 |
Open | 0.0600 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0600 - 0.0600 |
52-week range | 0.0200 - 0.0600 |
Volume | |
Avg. volume | 2,016 |
Market cap | 11.028M |
Beta (5Y monthly) | 1.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0200 |
Earnings date | 29 May 2023 - 02 June 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MISSISSAUGA, Ontario, April 25, 2023--MedX Health adds capital investor experience to its Board with the appointment of two new Directors.
MISSISSAUGA, Ontario, April 18, 2023--MedX Health and PharmaChoice announce agreement to launch commercialization pilot project for MedX's DermSecure teledermatology screening platform.
MISSISSAUGA, Ontario, March 20, 2023--MedX Health announces final closing of its previously announced Secured Convertible Debentures financing.
MISSISSAUGA, Ontario, February 15, 2023--MedX Health announces first closing of Secured Convertible Debenture financing for $765,000.
MISSISSAUGA, Ontario, January 30, 2023--MedX Health announces Secured Convertible Debt private placement financing to raise up to $1.5 million.
MISSISSAUGA, Ontario, January 06, 2023--MedX Health announces closing of $1.5 million secured convertible debenture financing.
MISSISSAUGA, Ontario, October 24, 2022--MedX Health announces closing of private placement of its Series III Convertible Loan Notes for a total of $1.1 Million.
MISSISSAUGA, Ontario, September 09, 2022--MedX Health announces closing of further subscriptions for $350,000 and application for extension of price protection for private placement financing.
MISSISSAUGA, Ontario, August 11, 2022--MedX Health applies for extension of price protection for private placement.
MISSISSAUGA, Ontario, August 02, 2022--MedX Health strengthens its senior management and sales teams with the addition of former Medtronic Business Director Tarek El Hoss.
MISSISSAUGA, Ontario, July 26, 2022--MedX Health announces partnership with Central Health to launch MedX's DermSecure® skin screening services in Newfoundland and Labrador.
MISSISSAUGA, Ontario, July 14, 2022--MedX Health announces the closing of the first tranche of its non-brokered private placement of convertible loan notes.
MISSISSAUGA, Ontario, July 07, 2022--MedX Health announces amendment to terms of its non-brokered private placement of up to $4 million convertible loan notes.
MISSISSAUGA, Ontario, June 30, 2022--MedX Health announces non-brokered private placement of up to $4 million of convertible loan notes.
MISSISSAUGA, Ontario, June 21, 2022--MedX Health receives final acceptance from the TSX Venture Exchange with respect to the issuance of Series II Convertible Loan Notes.
MISSISSAUGA, Ontario, June 14, 2022--MedX Health appoints CEO Naman Demaghlatrous to its Board of Directors and grows its DermSecure skin screening platform's global presence.
MISSISSAUGA, Ontario, May 30, 2022--MedX Health announces its first quarter 2022 financial results.